Lawsuits and Intrigue Over 3M Diagnostic Test
By BARRY MEIER
A suit over a test to be marketed by 3M has escalated into a legal morass ensnaring 3M’s chief executive, Britain’s secretary of defense and a Washington lawyer.
A suit over a test to be marketed by 3M has escalated into a legal morass ensnaring 3M’s chief executive, Britain’s secretary of defense and a Washington lawyer.
Despite a 11 percent drop in profit at Eli Lilly, revenue rose 9 percent and the company increased its earnings forecast.
This chilled summer soup has an unusual crunchy texture.
The F.D.A. cautioned against using Multaq for a long-term form of atrial fibrillation.
Dr. Stephen Rose of the Foundation Fighting Blindness responds to reader questions about Stargardt's disease.
The new Ion Torrent machine costs $49,000 and takes just two hours to sequence DNA, but its inventor says it will take years to make sense of much of the data it reveals.
While the chemical was recently labeled a carcinogen, undertakers insist nothing else preserves the body well enough for public viewing or for shipping.
The absence of a protein that coats sperm and allows them to reach an egg more easily could be the potential cause for unexplained cases of male infertility.
The government will require the drug, which could challenge Plavix, to carry a strong warning label.
A medical advisory panel suggested all health plans cover birth control under the new health care law.
Diana Nyad, 61, aims to set a record by swimming across the shark-infested Straits of Florida in 60 hours.
Stephen Rose of the Foundation Fighting Blindness responds to reader questions about macular degeneration.
An exercise physiologist and other experts said that contrary to popular wisdom, they could find no scientific evidence that a softer surface is beneficial to runners.
The Times's fitness guinea pig, Karen Barrow, tries a Figure 4 barre workout. For more Gym Class videos, go to nytimes.com/well.
How would your life be different if you couldn’t read a book, see your spouse’s face or drive? Here, six men and women speak about their lives with progressive vision loss.
The big drug maker Gilead Sciences has taken an important step in making AIDS drugs more available worldwide. But obstacles remain.
In the news: Weight gain, a presidential candidate and new Ivy League rules. Test your knowledge of this week’s health news.
The most detailed long-term analysis of the factors that influence weight gain shows that conventional wisdom may not be the best approach.
Danish researchers found an association between contact allergies and a decreased rate of skin and breast cancer.
Dr. Stephen Rose of the Foundation Fighting Blindess responds to readers’ questions about nutrients and vitamins to counter macular degeneration.
The company’s results also reflected flat sales in the United States and costs related to litigation and restructuring.
Celery brings together the elements of this surprising soup.
Counterintuitive though it may seem, this cold soup is actually comforting.
On most days Giovanna Poli acts like a typical 12-year-old, but she is living with sickle cell disease.
Articles in this series examine issues arising from the increasing use of medical radiation and the new technologies that deliver it.
First-person accounts of patients' everyday challenges.
Epilepsy | Alzheimer's | Migraines | Psoriasis | Alopecia | See All »